| Kay S Williams, APNP | |
|
1025 Marsh St, Mankato, MN 56001-4752 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Kay S Williams |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 1025 Marsh St, Mankato, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134765233 | NPI | - | NPPES |
| 7067 | Other | MN | CERTIFIED NURSE PRACTITIONER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 7067 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Health System - Mankato | Mankato, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic Health System-southwest Minnesota Region | 4688585771 | 533 |
News Archive
Doctors in Denmark have succeeded in producing a two-cell embryo after ovarian tissue was removed, frozen, and then thawed and replaced two years later.
From the benefits of wearable devices for remote patient monitoring to opportunities for big-data applications to a changing regulatory environment, the Wireless Health 2014 international conference here Oct. 29 – 31 aims to disseminate the latest advances and promising prospective developments in mobile health.
Midostaurin added to standard chemotherapy is the first targeted treatment to improve survival of a high-risk, genetically defined subgroup of patients with acute myeloid leukemia (AML), reported Dr. Richard Stone, of Dana-Farber Cancer Institute, on behalf of the Alliance for Clinical Trials in Oncology group, in a plenary session at the 57th American Society of Hematology Annual Meeting and Exposition in Orlando.
In one of the most tightly controlled trials ever conducted of drugs used to treat sexually transmitted infections, researchers at the University of Alabama at Birmingham have confirmed that azithromycin remains effective in the treatment of urogenital chlamydia.
› Verified 6 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545422 PECOS PAC ID: 4688585771 Enrollment ID: O20031110000134 |
News Archive
Doctors in Denmark have succeeded in producing a two-cell embryo after ovarian tissue was removed, frozen, and then thawed and replaced two years later.
From the benefits of wearable devices for remote patient monitoring to opportunities for big-data applications to a changing regulatory environment, the Wireless Health 2014 international conference here Oct. 29 – 31 aims to disseminate the latest advances and promising prospective developments in mobile health.
Midostaurin added to standard chemotherapy is the first targeted treatment to improve survival of a high-risk, genetically defined subgroup of patients with acute myeloid leukemia (AML), reported Dr. Richard Stone, of Dana-Farber Cancer Institute, on behalf of the Alliance for Clinical Trials in Oncology group, in a plenary session at the 57th American Society of Hematology Annual Meeting and Exposition in Orlando.
In one of the most tightly controlled trials ever conducted of drugs used to treat sexually transmitted infections, researchers at the University of Alabama at Birmingham have confirmed that azithromycin remains effective in the treatment of urogenital chlamydia.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kay S Williams, APNP 1025 Marsh St, Mankato, MN 56001-4752 Ph: () - | Kay S Williams, APNP 1025 Marsh St, Mankato, MN 56001-4752 Ph: (507) 284-2511 |
News Archive
Doctors in Denmark have succeeded in producing a two-cell embryo after ovarian tissue was removed, frozen, and then thawed and replaced two years later.
From the benefits of wearable devices for remote patient monitoring to opportunities for big-data applications to a changing regulatory environment, the Wireless Health 2014 international conference here Oct. 29 – 31 aims to disseminate the latest advances and promising prospective developments in mobile health.
Midostaurin added to standard chemotherapy is the first targeted treatment to improve survival of a high-risk, genetically defined subgroup of patients with acute myeloid leukemia (AML), reported Dr. Richard Stone, of Dana-Farber Cancer Institute, on behalf of the Alliance for Clinical Trials in Oncology group, in a plenary session at the 57th American Society of Hematology Annual Meeting and Exposition in Orlando.
In one of the most tightly controlled trials ever conducted of drugs used to treat sexually transmitted infections, researchers at the University of Alabama at Birmingham have confirmed that azithromycin remains effective in the treatment of urogenital chlamydia.
› Verified 6 days ago
Cassy Kay Burton, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1400 Madison Ave Ste 352, Mankato, MN 56001 Phone: 507-387-3195 | |
Elizabeth Cumberland, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Omar G Ferrer, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Laura Renee Fisher, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Mrs. Season Marie Hoffman, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1230 E Main St, Mankato, MN 56001 Phone: 507-625-1811 | |
Darla R Theobald, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Danielle Wendinger, RN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1230 E Main St, Mankato, MN 56001 Phone: 507-625-1811 |